FDA Natural Family Planning Review

The U.S. Food and Drug Administration (FDA) has published a review document pertaining to Natural Family Planning methods. The document, posted on March 13, 2026, is available under docket number FDA-2026-P-2641-0005. As this appears to be a guidance or informational document, it is likely non-binding.

Regulated entities, particularly drug and medical device manufacturers, as well as healthcare providers involved with family planning services, should review the posted document to understand any updated information or recommendations. Given the nature of guidance documents, immediate compliance actions may not be required, but awareness of the FDA's current stance on Natural Family Planning is advisable for operational and product development considerations.